Trivarx Ltd has released a press release.
Supplementary Prospectus
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from TrivarX
- MEB Begins Implementation of ilumen In the United Kingdom
- Underwritten Share Purchase Plan Update
- MEB to Raise up to $3.5m By Way of a Placement and SPP
- Medibio Granted CE Mark Approval for MEBsleep
- Consumer Mental Health App Initial testing phase commenced
Later from TrivarX
- MEB Share Purchase Plan Closes Strongly Oversubscribed
- Consumer Mental Health App Development - Second Test Phase
- Re-submission of FDA 510(k) application
- Medibio strengthens its IP protection
- MEB Appoints R&CPMK As Communications Agency in the US
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX